Dominique Baeten Selected Research

Spondylarthritis (Spinal Arthritis)

12/2014	Autoimmunity: break-through in the diagnosis and treatment of immune-mediated inflammatory diseases.
12/2011	Interleukin-23: a central cytokine in the pathogenesis of spondylarthritis.
4/2011	Mechanisms and clinical relevance of TRAIL-triggered responses in the synovial fibroblasts of patients with rheumatoid arthritis.
7/2009	Alterations of the synovial T cell repertoire in anti-citrullinated protein antibody-positive rheumatoid arthritis.
4/2009	In vitro spontaneous osteoclastogenesis of human peripheral blood mononuclear cells is not crucially dependent on T lymphocytes.
4/2009	Absence of a classically activated macrophage cytokine signature in peripheral spondylarthritis, including psoriatic arthritis.
11/2008	Identification of interleukin-7 as a candidate disease mediator in spondylarthritis.
3/2008	The abundant synovial expression of the RANK/RANKL/Osteoprotegerin system in peripheral spondylarthritis is partially disconnected from inflammation.
6/2006	Identification of synovial biomarkers of response to experimental treatment in early-phase clinical trials in spondylarthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dominique Baeten Research Topics

Disease

33	Rheumatoid Arthritis 01/2019 - 03/2002
27	Inflammation (Inflammations) 01/2020 - 03/2002
22	Ankylosing Spondylitis 01/2020 - 12/2002
15	Arthritis (Polyarthritis) 05/2015 - 01/2004
13	Synovitis 01/2012 - 02/2004
12	Spondylarthropathies 01/2016 - 03/2002
11	Necrosis 01/2018 - 03/2002
9	Spondylarthritis (Spinal Arthritis) 12/2014 - 06/2006
8	Psoriatic Arthritis 01/2019 - 01/2005
7	Experimental Arthritis 06/2021 - 10/2008
7	Axial Spondyloarthritis 01/2020 - 09/2014
5	Crohn Disease (Crohn's Disease) 01/2016 - 09/2002
5	Osteoarthritis 11/2011 - 07/2005
4	Autoimmune Diseases (Autoimmune Disease) 06/2021 - 01/2010
4	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2020 - 01/2017
4	Hyperplasia 01/2016 - 01/2005
3	Infections 01/2019 - 07/2005
2	Rheumatic Diseases (Rheumatism) 01/2014 - 01/2013
1	Hidradenitis Suppurativa 11/2021
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 06/2021
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 06/2021
1	Fibrosis (Cirrhosis) 06/2021
1	type 2C Congenital disorder of glycosylation 01/2019
1	Multiple Sclerosis 01/2019
1	Skin Diseases (Skin Disease) 01/2018
1	Non-Radiographic Axial Spondyloarthritis 01/2018
1	Back Pain (Backache) 01/2017
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2017
1	Neutropenia 12/2015
1	Body Weight (Weight, Body) 12/2015
1	Candidiasis (Moniliasis) 12/2015
1	Gout 05/2014
1	Melanoma (Melanoma, Malignant) 03/2014
1	Abscess 11/2013
1	Disease Progression 04/2013
1	Asthma (Bronchial Asthma) 01/2013
1	Hepatitis B 01/2013

Drug/Important Bio-Agent (IBA)

19	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 03/2002
15	CytokinesIBA 01/2020 - 10/2002
15	Interleukin-17 (Interleukin 17)IBA 01/2020 - 04/2009
11	Proteins (Proteins, Gene)FDA Link 06/2021 - 01/2005
11	Infliximab (Remicade)FDA Link 08/2014 - 03/2002
10	Biomarkers (Surrogate Marker)IBA 01/2018 - 09/2004
9	Monoclonal AntibodiesIBA 01/2018 - 03/2002
7	Biological ProductsIBA 01/2020 - 08/2003
7	LigandsIBA 01/2019 - 12/2002
7	secukinumabIBA 06/2017 - 11/2013
7	Etanercept (Enbrel)FDA Link 08/2014 - 01/2004
6	AutoantibodiesIBA 12/2014 - 04/2005
5	bimekizumabIBA 11/2021 - 01/2018
5	Interleukin-23 (Interleukin 23)IBA 01/2020 - 12/2011
5	Anti-Citrullinated Protein AntibodiesIBA 01/2018 - 08/2005
4	C-Reactive ProteinIBA 01/2018 - 10/2016
4	ImmunosorbentsIBA 05/2014 - 09/2004
4	EnzymesIBA 05/2014 - 09/2004
4	AntibodiesIBA 08/2013 - 03/2008
3	Leukocyte L1 Antigen Complex (Calgranulin)IBA 01/2017 - 09/2014
3	CollagenIBA 03/2014 - 04/2013
3	AutoantigensIBA 03/2014 - 06/2003
3	acetyl 4-aminosalicylic acidIBA 04/2013 - 08/2005
3	Messenger RNA (mRNA)IBA 11/2011 - 11/2008
3	ChemokinesIBA 07/2008 - 10/2002
2	InterleukinsIBA 01/2020 - 01/2019
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 07/2005
2	HLA-B27 Antigen (HLA B27 Antigen)IBA 01/2015 - 06/2006
2	Toll-Like Receptor 4IBA 05/2014 - 07/2005
2	Immunomodulating AgentsIBA 01/2013 - 12/2010
2	Immunoglobulin M (IgM)IBA 08/2011 - 07/2005
2	OsteoprotegerinIBA 04/2011 - 03/2008
2	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 07/2008 - 08/2006
2	Matrix Metalloproteinases (MMPs)IBA 06/2006 - 09/2004
2	EpitopesIBA 08/2005 - 02/2004
2	Interleukin-10 (Interleukin 10)IBA 02/2004 - 03/2002
1	Bleomycin (Blenoxane)FDA LinkGeneric 06/2021
1	seletalisibIBA 01/2020
1	Immunoglobulin G (IgG)IBA 01/2019
1	Methotrexate (Mexate)FDA LinkGeneric 01/2019
1	Certolizumab Pegol FDA Link 01/2019
1	golimumab FDA Link 01/2019
1	risankizumabIBA 01/2018
1	Tumor Necrosis Factor InhibitorsIBA 01/2017
1	nilotinib FDA Link 10/2016
1	Interleukin-9 (Interleukin 9)IBA 01/2016
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016
1	Ustekinumab (CNTO 1275)FDA Link 07/2014
1	Interleukin-12 (IL 12)IBA 07/2014
1	brodalumabIBA 07/2014
1	ixekizumabIBA 07/2014
1	Uric Acid (Urate)IBA 05/2014
1	Rituximab (Mabthera)FDA Link 01/2014
1	B-Cell Maturation AntigenIBA 08/2013
1	Cyclophilins (Cyclophilin)IBA 08/2013
1	B-Cell Activating FactorIBA 08/2013
1	Fibrinogen (Factor I)FDA Link 04/2013
1	VaccinesIBA 01/2013
1	Polysaccharides (Glycans)IBA 01/2013
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 08/2012

Therapy/Procedure

18	Therapeutics 01/2020 - 03/2002
1	Ligation 01/2017
1	Biological Therapy 01/2014